Loading…

Nanoparticle biosensors for cardiovascular disease detection

[Display omitted] •Nanoparticles can be designed for early cardiovascular diseases (CVDs) detection.•Nanomaterials are used as the modifiers on the sensor for signal intensification.•Having the large surface area in nanoparticles can result effective immobilization.•The use of different type of nano...

Full description

Saved in:
Bibliographic Details
Published in:Clinica chimica acta 2024-12, Vol.567, p.120094, Article 120094
Main Authors: Saadh, Mohamed J., Muhammad, Faris Anad, Albadr, Rafid Jihad, Bishoyi, Ashok Kumar, Ballal, Suhas, Bareja, Lakshay, Naidu, K.Satyam, Rizaev, Jasur, Taher, Waam Mohammed, Alwan, Mariem, Jawad, Mahmood Jasem, Ali Al-Nuaimi, Ali M.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Nanoparticles can be designed for early cardiovascular diseases (CVDs) detection.•Nanomaterials are used as the modifiers on the sensor for signal intensification.•Having the large surface area in nanoparticles can result effective immobilization.•The use of different type of nanoparticles for CVD detection was discussed.•AuNPs have been used more than other nanoparticles in CVD biosensors. Early detection and management of cardiovascular diseases (CVDs) are crucial for patient survival and long-term health. CVD biomarkers such as cardiac Troponin-I (cTnI), N-terminal pro-brain natriuretic peptide (NT-proBNP), creatine kinase MB (CK-MB), Galectin-3 (Gal-3), etc are released into the circulation following heart muscle injury, ie, acute myocardial infarction (AMI). Biosensor technology including the use of nanoparticles can be designed to target specific biomarkers associated with CVD, enabling early detection and more rapid intervention to decrease morbidity and mortality. To date, with the combination of developed nanoparticles, several optical and electrochemical-based biosensors have successfully been used detection of CVD biomarkers. Nanomaterials, when introduced as the modifiers of sensor surfaces like electrodes and gold chips, can result in the more comprehensive and more effective immobilization of capture molecules, ie, antibodies, aptamers and other ligands, due to their large surface area. In recent years, inorganic nanoparticles have regularly been used in the production of biosensors mostly due to their excellent response intensification, adaptable functionalization chemistry, shape control, good biocompatibility, and great stability. In this review, we discuss the application of different kinds of nanoparticles for the sensitive and specific detection of CVD biomarkers.
ISSN:0009-8981
1873-3492
1873-3492
DOI:10.1016/j.cca.2024.120094